↓ Skip to main content

A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma

Overview of attention for article published in BMC Cancer, June 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma
Published in
BMC Cancer, June 2021
DOI 10.1186/s12885-021-08375-6
Pubmed ID
Authors

Jiujie Cui, Haiyan Yang, Jue Liu, Donghui Chen, Jiong Hu, Haiyan Zhang, Yu Wang, Ting Han, Tiebo Mao, Feng Jiao, Ewelina Biskup, Yaotian Pan, Min Liu, Liwei Wang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 12%
Student > Bachelor 2 8%
Student > Doctoral Student 1 4%
Librarian 1 4%
Professor 1 4%
Other 1 4%
Unknown 16 64%
Readers by discipline Count As %
Medicine and Dentistry 3 12%
Biochemistry, Genetics and Molecular Biology 2 8%
Agricultural and Biological Sciences 1 4%
Economics, Econometrics and Finance 1 4%
Engineering 1 4%
Other 0 0%
Unknown 17 68%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 January 2022.
All research outputs
#14,875,637
of 22,908,162 outputs
Outputs from BMC Cancer
#3,682
of 8,330 outputs
Outputs of similar age
#241,655
of 444,753 outputs
Outputs of similar age from BMC Cancer
#94
of 276 outputs
Altmetric has tracked 22,908,162 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,330 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,753 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 276 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.